Paul H. Johnson

Paul H. Johnson discloses dealings in Marina Biotech, Inc. to SEC (Form 4). In total, 14 filings cover trades dated from 23 January 2006 to 5 October 2007.

Sales make up the whole of the open-market record (6 sales, €768k). Outside the open market, there are 3 share grants and 5 option exercises. So far in 2007, the count stands at no purchases and 5 sales.

Most recently, on 9 October 2007, the filings show a share grant worth €7,112 in Marina Biotech, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.